Variants of the PTPN11 Gene in Mexican Patients with Noonan Syndrome
Genes · 2024
DOI: 10.3390/genes15111379 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2024. Verfasst von Paola Montserrat Zepeda-Olmos und 5 weiteren Autor:innen. Beteiligte Einrichtung: División de Genética, Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social, Guadalajara 44360, Jalisco, Mexico. Hauptthemen laut MEDLINE: Noonan Syndrome, Protein Tyrosine Phosphatase, Non-Receptor Type 11. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: IMSS (R-2021-785-068).
Abstract (Originalsprache)
Background/Objectives: Noonan syndrome (NS) is a genetic multisystem disease characterized by distinctive facial features, short stature, chest deformity, and congenital heart defects. NS is caused by gene variants of the RAS/MAPK pathway, with PTPN11 accounting for about 50% of cases. This study aimed to identify PTPN11 pathogenic variants in Mexican patients with NS to enhance our understanding of the disease in this population.
Methods
This study included 91 probands and 60 relatives, all of which were clinically evaluated by a geneticist. Sanger sequencing was used to screen the entire PTPN11 gene.
Results
Twenty-one previously reported pathogenic variants were identified in 47.3% of the probands. The most frequently occurring were p.Asn308Asp (16.3%) and p.Met504Val (16.3%). Variants p.Tyr279Cys and p.Thr468Met were found exclusively in patients with lentiginosis. Eighty-three percent of patients carried a variant in one of the three exons (3, 8, or 13) where the greatest genetic diversity was observed. Common clinical findings identified in probands included short stature (82%), cardiac anomalies (70.7%), short neck (68.4%), and pectus excavatum (63.2%), although features represented by only one patient each were also detected.
Conclusions
This study confirmed the clinical diagnosis of NS in 43 probands and 11 relatives, and further genetic analysis of the remaining 48 probands is required to identify the causal variant. The genetic and clinical variability observed in our cohort was consistent with reports from other populations, underscoring the importance of comprehensive care for all patients. This research provides the most extensive clinical and molecular characterization of NS in Mexican patients, identifying pathogenic variants of PTPN11.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- División de Genética, Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social, Guadalajara 44360, Jalisco, Mexico.
- Doctorado en Genética Humana, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada 950, Independencia Oriente, Guadalajara 44340, Jalisco, Mexico.
- Unidad Médica de Alta Especialidad, Hospital de Pediatría del Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Belisario Domínguez 735, La Perla, Guadalajara 44360, Jalisco, Mexico.
ORCID-Profile: Eduardo Esparza-García, Kiabeth Robles-Espinoza, Perla Graciela Rodríguez Gutiérrez
Förderung
- IMSS (R-2021-785-068)
Zitieren
APA
Zepeda-Olmos, P. M., Esparza-García, E., Robles-Espinoza, K., González-García, J. R., Rodríguez Gutiérrez, P. G., & Magaña-Torres, M. T. (2024). Variants of the PTPN11 Gene in Mexican Patients with Noonan Syndrome. Genes. https://doi.org/10.3390/genes15111379
Vancouver
Zepeda-Olmos PM, Esparza-García E, Robles-Espinoza K, González-García JR, Rodríguez Gutiérrez PG, Magaña-Torres MT. Variants of the PTPN11 Gene in Mexican Patients with Noonan Syndrome. Genes. 2024. doi:10.3390/genes15111379
BibTeX
@article{ZepedaOlmos2024,
author = {Zepeda-Olmos, Paola Montserrat and Esparza-García, Eduardo and Robles-Espinoza, Kiabeth and González-García, Juan Ramón and Rodríguez Gutiérrez, Perla Graciela and Magaña-Torres, María Teresa},
title = {Variants of the PTPN11 Gene in Mexican Patients with Noonan Syndrome},
journal = {Genes},
year = {2024},
doi = {10.3390/genes15111379}
}
EUVIMED